Biomaterials Market: By Type; By Application; By Geography - Forecast 2016-2021

  • ID: 4532367
  • Report
  • 168 pages
  • IndustryARC
1 of 3
Biomaterials are various groups of materials apart from drugs, which is synthetic or natural in origin, and can be utilized for a period of time. It augments or replaces any tissue as well as organ or function of the body partly or fully in order to preserve or advance the quality of life of the individual. Biomaterials are widely used in medical applications and have benign function like it is being used for heart valve or hydroxyapatite hip implants and more. Major biomaterials that are used in humans are synthetic polymer owing to its characteristics of minimizing the threat of disease transmission. Moreover, biomaterials do reduce the generation of debris and its biocompatible chemical composition and avoids adverse tissue reaction.

The materials are highly useful to replace damaged tissue and improve body functions. The increasing consideration towards the safety of human health as well as increased funds & grants by government bodies worldwide, have further resulted in more consumption of biomaterials in various industries as well as regions. Major types of biomaterials commercially available are metals & alloys, ceramics, polymers and natural materials. The report also focuses on different geographic regions and the key countries in terms of changing trends in biomaterials market in various fields.

Ceramics are widely used as artificial bones. They are also used in cancer treatment and drug delivery systems. Moreover, bioactive ceramics and glasses, mainly hydroxyapatite, various calcium phosphates and bioactive glasses, are used as coatings to improve bone bonding. Metals are another vital materials used as biomaterials. They majorly find their use in applications such as orthopedic, soft bone or cartilage replacement, dentistry and more. Additionally, polymers have numerous applications including drug delivery systems, gene delivery systems, and scaffolds. However, targeting and gene delivery is the most exciting challenges.

The end user industry is the major driver for the biomaterials market to grow. Biomaterials find their applications in various segments of medical applications like orthopedics, cardiovascular, tissue engineering, neurology, dental, 3D printing and more. North America dominated the global biomaterials market. The biomaterials based research, growing demand in plastic surgery; increase in cancer incidents in U.S. is all set to drive the demand of biomaterials materials in North America region. Major players involved in this market are mainly concentrating on R&D initiatives and new product developments to cater the needs of customers. Moreover, booming medical & healthcare industry will directly impact the demand of the biomaterials over the foreseeable period.

APAC, especially Japan is the fastest growing markets for biomaterials as it a world leader in dialysis membranes and artificial kidneys, with more than 50% of the world market. Countries that will experience strong growth include China, Vietnam, India, China, Sri Lanka, Myanmar and Bangladesh. In the recent years, with increasing emphasis on health safety and reducing, end-product manufacturers have preferred this material.

The global biomaterials market is evaluated based on key attributes such as types, application and others. Each of the segmentations in the report has been studied to give comprehensive analysis of global biomaterials market. The overall market has also been consolidated from the perspective of different geographic locations into standard geographic regions and key economies for this market. Additionally, this report encompasses opportunity analysis, porter analysis, pricing analysis and market forces such as drivers, constraints and challenges that are involved to drive the overall market.

Sample companies profiled in this report are:
BASF SE
Bayer AG
Royal DSM
10+
This report gives detailed information about the product value chain right from the beginning which includes raw materials till end-use. The market is analyzed based on the key attributes such as the power in the hands of producers and consumers, analysis on the degree of competition, and threats from substitutes and new entrants. The study includes the demand of this particular market on a global and regional scale for a six year period of 2016-2021, both in terms of volume(kilo tons) and revenue($ million).
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. MARKET OVERVIEW

2. EXECUTIVE SUMMARY

3. BIOMATERIALS MARKET - LANDSCAPE
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. Top 5 Financials Analysis

4. BIOMATERIALS MARKET FORCES
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Market Attractiveness
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitutes
4.4.5. Rivalry Among the Competitors

5. BIOMATERIALS - STRATEGIC ANALYSIS
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunity Analysis
5.4. Supplier & Distributors
5.5. Market Life Cycle Analysis

6. BIOMATERIALS MARKET – BY TYPE
6.1. Metals & Alloys
6.1.1. Stainless Steel
6.1.2. Cobalt-Chrome Alloys
6.1.3. Titanium
6.1.4. Others
6.2. Ceramics
6.2.1. Calcium Phosphate Hydroxypatite (HAP)
6.2.2. Aluminum Oxide
6.2.3. Zirconia
6.2.4. Calcium Sulphate
6.2.5. Others
6.3. Polymers
6.3.1. Polyethylene
6.3.2. Polypropylene
6.3.3. Polyester
6.3.4. Polyurethane
6.3.5. Polyvinyl Chloride
6.3.6. Others
6.4. Natural material
6.4.1. Silk
6.4.2. Collagen & Gelatin
6.4.3. Cellulose
6.4.4. Chitosan
6.4.5. Others

7. BIOMATERIALS MARKET – BY APPLICATION
7.1. Orthopedics
7.2. Cardiovascular
7.3. Tissue Engineering
7.4. Neurology
7.5. Ophthalmology
7.6. Dental
7.7. Plastic Surgery
7.8. 3D Printing
7.9. Others

8. BIOMATERIALS MARKET – BY GEOGRAPHY
8.1. North America
8.1.1. U.S.
8.1.2. Canada
8.1.3. Mexico
8.2. Europe
8.2.1. Germany
8.2.2. U.K.
8.2.3. France
8.2.4. Rest of Europe
8.3. APAC
8.3.1. China
8.3.2. Japan
8.3.3. India
8.3.4. Rest of APAC
8.4. RoW

9. MARKET ENTROPY
9.1. New Product Launches
9.2. M&A’s, Collaborations, JVs And Partnerships

10. COMPANY PROFILES
10.1. BASF SE
10.2. Royal DSM
10.3. Invibio Ltd. (Subsidiary of Victrex PLC)
10.4. Corbion N.V
10.5. Wright Medical Technology, Inc.
10.6. Collagen Matrix, Inc.
10.7. Covalon Technologies Ltd.
10.8. Evonik Industries AG
10.9. Zimmer Biomet Holdings, Inc.
10.10. Vornia Biomaterials.
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"

11. APPENDIX
11.1. Abbreviations
11.2. Sources
11.3. Research Methodology
11.4. Bibliography
11.5. Compilation Of Expert Insights
11.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll